Skip to content
PubMed This is a summary of 57 peer-reviewed journal articles Updated
Gastroenterology · Autoimmune Enteropathy

Autoimmune Enteropathy: A Patient Guide

At a Glance

Autoimmune enteropathy is a rare immune disorder that damages the small intestine and can cause severe diarrhea, dehydration, weight loss, and poor growth. Diagnosis often requires biopsy and careful exclusion of similar conditions, while treatment combines immune suppression with intensive nutrition support.

Autoimmune enteropathy (AIE) is an ultra-rare condition characterized by an inappropriate immune system attack on the lining of the small intestine. In a healthy body, the immune system helps protect the digestive tract; in AIE, however, immune cells mistakenly target the delicate, finger-like projections called villi that are responsible for absorbing nutrients from food. This persistent attack causes the villi to flatten and disappear, severely impairing the body’s ability to take in water, calories, and essential vitamins. The hallmark of the condition is severe, “intractable” diarrhea that does not improve with standard dietary changes, often resulting in significant weight loss or a failure to grow in children [1][2].

What I Should Do Today

  • Contact your treating team promptly to establish a coordinated plan of care.
  • Protect hydration and nutrition, but do not make major dietary or medication changes alone.
  • Know the urgent symptoms: If you or your child experience fainting, confusion, very dark or little urine, rapid heartbeat, inability to keep fluids down, blood in the stool, or worsening abdominal pain (or for a child, markedly fewer wet diapers, no tears, or unusual sleepiness), seek emergency care immediately.

Because AIE is so rare, the process of reaching a diagnosis is often a complex journey of exclusion. It is frequently mistaken for more common conditions, such as celiac disease or certain immunodeficiencies, because they all share the same pattern of intestinal damage. To find the correct answer, doctors must look deep into the microscopic details of intestinal biopsies, interpreting supportive findings alongside your clinical history. Distinguishing AIE from its mimics is a critical first step, as the treatments required for AIE are far more intensive than those used for common digestive disorders [3][4].

The nature of the condition often depends on when it first appears, with researchers identifying distinct pediatric and adult-onset forms. In infants, AIE is frequently “syndromic,” meaning it is part of a broader genetic disorder—such as IPEX syndrome—that affects multiple organ systems, including the skin and the hormone-producing glands. In these cases, the body lacks the specific genetic “peacekeepers” needed to restrain the immune system. In adults, the condition is more likely to be an isolated autoimmune event or associated with other established autoimmune diseases, requiring a tailored diagnostic approach that often includes genetic testing for younger patients [5][6].

Managing AIE requires a dual approach that addresses both the immune system and the body’s immediate survival needs. Treatment typically begins with powerful medications to suppress the overactive immune response and allow the intestinal lining a chance to heal. Simultaneously, because the gut may be too damaged to absorb food adequately, many patients require intensive nutritional support, such as total parenteral nutrition (TPN), which delivers nutrients directly into the bloodstream. This comprehensive strategy aims to stabilize the body while the immune-suppressing medications work to achieve long-term remission [7][8].

Living with AIE is a chronic process of careful monitoring and adaptation. Once the initial inflammation is under control, the focus shifts to maintaining “mucosal healing” through individualized follow-up and blood work to track nutritional markers. Because the medications used to manage AIE “turn down” the immune system, patients and their care teams must remain vigilant against the risk of infections and other long-term side effects. While the diagnosis is life-changing, a dedicated multidisciplinary team can help navigate these challenges, focusing on restoring the health of the intestine and improving the patient’s quality of life [9][10].

Common questions in this guide

What is autoimmune enteropathy, and how does it affect the body?
Autoimmune enteropathy is a rare condition in which the immune system attacks the lining of the small intestine. Damage to the intestine’s nutrient-absorbing villi can cause persistent severe diarrhea, dehydration, weight loss, and poor growth in children.
How do doctors diagnose autoimmune enteropathy?
Doctors use the symptoms, medical history, blood tests, and microscopic examination of small-intestine biopsy samples. They also work to rule out conditions with similar intestinal damage, such as celiac disease and some immune-system disorders; genetic testing may be considered, especially for children with early-onset disease.
What treatments are used for autoimmune enteropathy?
Treatment usually combines medicines that suppress the overactive immune response with intensive nutrition and hydration support. If the intestine cannot absorb enough nutrients, total parenteral nutrition can deliver calories and nutrients directly into the bloodstream while treatment takes effect.
Could IPEX syndrome be related to autoimmune enteropathy in a child?
In infants and young children, autoimmune enteropathy can occur as part of a broader genetic disorder such as IPEX syndrome. Doctors may consider genetic evaluation when symptoms begin early or when skin problems, hormone-related conditions, or other immune problems are also present.
What should I watch for if autoimmune enteropathy causes dehydration?
Seek emergency care for fainting, confusion, very dark or very little urine, a rapid heartbeat, inability to keep fluids down, blood in the stool, or worsening abdominal pain. In a child, markedly fewer wet diapers, no tears, or unusual sleepiness are urgent warning signs.
How is autoimmune enteropathy monitored over the long term?
Follow-up usually includes a coordinated team and blood tests to monitor nutrition and other health markers. Because immune-suppressing medicines can increase infection risk and cause other side effects, the care team must monitor treatment safety as well as intestinal healing.

Get notified when new evidence is published on Primary autoimmune enteropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Advances and challenges in diagnosing and managing adult autoimmune enteropathy.

    Christodoulidis G, Agko SE, Kouliou MN, et al.

    World journal of gastroenterology 2025; (31(2)):99118 doi:10.3748/wjg.v31.i2.99118.

    PMID: 39811507
  2. 2

    Pediatric autoimmune disorders with gastrointestinal expressions: from bench to bedside.

    Francalanci P, Cafferata B, Alaggio R, et al.

    Pathologica 2022; (114(1)):32-39 doi:10.32074/1591-951X-339.

    PMID: 34856606
  3. 3

    Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital.

    Li MH, Ruan GC, Zhou WX, et al.

    World journal of gastroenterology 2024; (30(19)):2523-2537 doi:10.3748/wjg.v30.i19.2523.

    PMID: 38817655
  4. 4

    Relieving the discrimination dilemma of adult autoimmune enteropathy and common variable immunodeficiency disease: two rare causes of chronic diarrhea and small intestinal villous atrophy.

    Li M, Wang Q, Chen Y, et al.

    Clinical rheumatology 2025; (44(8)):3353-3367 doi:10.1007/s10067-025-07523-8.

    PMID: 40622608
  5. 5

    Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review.

    Park JH, Lee KH, Jeon B, et al.

    Autoimmunity reviews 2020; (19(6)):102526 doi:10.1016/j.autrev.2020.102526.

    PMID: 32234571
  6. 6

    Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.

    van Wanrooij RLJ, Neefjes-Borst EA, Bontkes HJ, et al.

    Clinical and translational gastroenterology 2021; (12(8)):e00387 doi:10.14309/ctg.0000000000000387.

    PMID: 34333499
  7. 7

    Isolated Intestine Transplantation for Autoimmune Enteropathy: A Case Report.

    Soma D, Saxena R, Arman ME, et al.

    Transplantation proceedings 2020; (52(9)):2835-2838 doi:10.1016/j.transproceed.2020.08.007.

    PMID: 32854966
  8. 8

    Adult autoimmune enteropathy in autoimmune hepatitis patient. Case report and literature review.

    Iaquinto G, Panico L, Luongo G, et al.

    Clinics and research in hepatology and gastroenterology 2021; (45(3)):101673 doi:10.1016/j.clinre.2021.101673.

    PMID: 33744411
  9. 9

    Comprehensive insights into pathogenesis, diagnosis, treatment, and prognosis in adult autoimmune enteropathy.

    Li M, Xu T, Ruan G, et al.

    Orphanet journal of rare diseases 2025; (20(1)):208 doi:10.1186/s13023-025-03731-2.

    PMID: 40317016
  10. 10

    Successful Treatment of Refractory Autoimmune Enteropathy With Ustekinumab.

    Scheid JF, Misdraji J, Nath BJ, Yarze JC

    ACG case reports journal 2021; (8(1)):e00520 doi:10.14309/crj.0000000000000520.

    PMID: 33457439

This page provides general information about autoimmune enteropathy, its diagnosis, treatment, and supportive care; it is not medical advice. Your treating team should guide urgent care, nutrition, and medication decisions for you or your child.